Han Kun Law Offices covers the full scope of life sciences and healthcare matters, including representing major funds on their investments, advising on compliance and regulatory issues for pharmaceutical and healthcare companies, with expertise extending to competition, IP and litigation matters. The practice is spearheaded by Shanghai-based Yinshi Cao, excelling in private equity, venture capital investments and capital markets for start-ups and multinational companies. In Beijing, Aaron Zhou is equipped to handle cross-border and domestic M&A, private equity investments and pharmaceutical-related transactions, while in Shanghai, Aaron Gu has extensive experience in corporate, regulatory compliance and transactions in the biopharmaceutical, medical and healthcare sectors. Liming Yuan and Min Zhu are active in complex acquisitions and investments for multinational corporations.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The team is familiar with the pharmaceutical industry, rich experience in cross-border projects, fast feedback, strong legal documents and negotiation skills in English.’
- ‘The team has rich experience in pharmaceutical transactions. High work efficiency, very fast feedback, and timely problem solving.’
Key clients
- Bayer
- GSK
Work highlights
Advised 3SBio on the landmark exclusive licensing deal with Pfizer for the PD-1/VEGF Bispecific Antibody SSGJ-707,USD 1.25 billion upfront payment, up to USD 4.8 billion milestone payments, double-digit royalties based on net sales, plus USD 100 million equity investment.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Min Zhu
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Aaron Gu
Aaron Zhou
Practice head
Yinshi Cao
Other key lawyers
Aaron Zhou; Min Zhu; Liming Yuan; Shuhan Luo